Caricamento...
Immunotherapy in pancreatic adenocarcinoma—overcoming barriers to response
Pancreatic adenocarcinoma (PAC) remains one of the leading causes of cancer-related death. Despite multiple advances in targeted and immune therapies, the 5-year survival in advanced PAC remains poor. In this review, we discuss some of the unique aspects of the tumor microenvironment (TME) in PAC th...
Salvato in:
| Pubblicato in: | J Gastrointest Oncol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5848027/ https://ncbi.nlm.nih.gov/pubmed/29564181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2018.01.13 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|